Abbvie Inc. vs Alcon Inc.
ABBV vs ALC — side-by-side comparison from reported financials. ABBV leads 6, ALC leads 6 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Alcon Inc.
ALC · Healthcare
$64.11+1.55%Strong
| Metric | ABBV | ALC |
|---|---|---|
| Price | $276.43 | $64.11 |
| Market cap | $488B | $31.0B |
| Revenue (TTM) | $64.4B | $10.4B |
| Revenue growth | +1.8% | +6.1% |
| Net margin | 9.8% | 9.4% |
| Free cash flow | $18.2B | $1.74B |
| Net cash (debt) | ($56.2B) | ($3.84B) |
| 1-year price return | +19.8% | -14.0% |
| P/E | 77.4 | 38.4 |
| P/E vs own history (cheap-side %) | 23% | 99% |
| Dividend yield | 2.45% | 0.55% |
| Return on equity | 96% | 3% |
| Altman Z-score | 2.33 | 2.56 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 57,000 | 25,942 |
Full résumé-style profiles: ABBV CV · ALC CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.